Status:

TERMINATED

Effects of a Three-Month Low Calorie Diet Weight Loss Intervention on Knee Replacement Outcomes

Lead Sponsor:

NYU Langone Health

Conditions:

Obesity

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

Total Knee Replacement (TKR) significantly improves function, pain, and overall quality of life in patients with end-stage arthritis of the knee. However, studies show that obesity increases complicat...

Eligibility Criteria

Inclusion

  • BMI 35-45 kg/m2
  • Any ethnicity
  • Able to speak, read, and write in English
  • Have knee replacement surgery already planned by the surgeon
  • Plan to undergo knee replacement surgery within 3-6 months post LCD intervention
  • Willing to commute to NYU Langone Weight Management Clinic at the start of the dietary intervention, midway through, and end of intervention

Exclusion

  • Uncontrolled type 2 diabetes, defined as HbA1c \> 9%
  • If smokes cigarettes, must go through a 6 week cessation program first
  • Type 1 diabetes
  • Whey protein allergies
  • Soy allergies
  • Anyone in whom rapid weight loss is not indicated (e.g., ESRD or cirrhosis, metabolic cancer, abnormal 3 times UL liver enzyme labs)
  • Current untreated or uncontrolled eating disorder (e.g., binge eating, bulimia)
  • Rheumatoid arthritis
  • In case a previous knee replacement surgery was done, the participant should wait at least 1 year from previous date of surgery
  • Undergoing simultaneous bilateral knee replacement
  • Enrolled in a formal weight loss program
  • Taking anti-obesity medications
  • Coexisting psychotic conditions requiring hospitalization or more intense treatment (e.g., bipolar mood disorder, severe depression)
  • Abnormal CBC, and uric acid, must be treated prior to start of intervention
  • Higher than 5.5 mU/L or lower than 0.3 mU/L TSH must be treated prior to start of LCD intervention

Key Trial Info

Start Date :

July 25 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2021

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT04015011

Start Date

July 25 2019

End Date

September 30 2021

Last Update

April 8 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016